India is betting on biopharma to move beyond generics, but gaps in R&D, raw materials, regulation, talent and cold-chain logistics could determine how far the industry goes.
#Biologics #Roche #CentralGovernmentHealthScheme #NIPERs #CDSCO #ASEAN #SHAKTI
#Biologics #Roche #CentralGovernmentHealthScheme #NIPERs #CDSCO #ASEAN #SHAKTI
Is India ready for the biopharma revolution?
India is betting on biopharma to move beyond generics, but gaps in R&D, raw materials, regulation, talent and cold-chain logistics could determine how far the industry goes.
www.itln.in
September 28, 2026 at 7:48 AM
India is betting on biopharma to move beyond generics, but gaps in R&D, raw materials, regulation, talent and cold-chain logistics could determine how far the industry goes.
#Biologics #Roche #CentralGovernmentHealthScheme #NIPERs #CDSCO #ASEAN #SHAKTI
#Biologics #Roche #CentralGovernmentHealthScheme #NIPERs #CDSCO #ASEAN #SHAKTI